| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.075 | 0.1 |